MedPath

Randomized, closs-over study to compare the effect of cilnidipine and azelnidipine on microalbuminuria in patients with hypertension and chronic kidney disease

Not Applicable
Recruiting
Conditions
hypertensive patients with chronic kidney disease
Registration Number
JPRN-UMIN000008553
Lead Sponsor
Department of Cardiology and Nephrology, Mie University, Graduate School of Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

Not provided

Exclusion Criteria

1) Contraindication to calcium chanel blockers. 2) Patients who has already administered calcium channel blocker except for amlodipine. 3) Any serious comobidity(brain disease, heart disease, renal disease, hepatic disease) 4) The patients with pregnant or possibly pregnant 5) Sereous hypertension patients 6) Investigator judged as inappropriate for this study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath